Brevan Howard Capital Management’s DexCom DXCM Stock Holding History

Brevan Howard Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.09M	Sell	49,242 -2,266	-4%	-$158K	0.03%	401
2025 Q4	$3.42M	Buy	51,508 +24,977	+94%	+$1.61M	0.04%	321
2025 Q3	$1.79M	Buy	26,531 +21,592	+437%	+$1.71M	0.01%	615
2025 Q2	$431K	Buy	+4,939	New	+$387K	﹤0.01%	1418
2025 Q1	–	Sell	-3,350	Closed	-$261K	–	1230
2024 Q4	$261K	Buy	+3,350	New	+$248K	﹤0.01%	823
2024 Q1	–	Sell	-12,565	Closed	-$1.56M	–	1085
2023 Q4	$1.56M	Buy	12,565 +9,618	+326%	+$983K	0.02%	154
2023 Q3	$275K	Buy	+2,947	New	+$332K	﹤0.01%	262

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brevan Howard Capital Management's DXCM Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its DexCom (DXCM) stake by 4.4% in Q1 2026, selling an estimated $158K and leaving 49,242 shares worth $3.09M. The position accounts for 0.03% of the portfolio, ranked #401.

Brevan Howard Capital Management first reported a position in DXCM in Q3 2023 and has held it in 7 quarters since. The position peaked at $3.42M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Brevan Howard Capital Management held 49,242 shares of DexCom worth $3.09M as of Q1 2026.
Brevan Howard Capital Management sold 2,266 DexCom shares in Q1 2026, an estimated $158K.
DexCom made up 0.03% of Brevan Howard Capital Management's portfolio in Q1 2026, its #401 holding.
Brevan Howard Capital Management first reported a position in DexCom in Q3 2023 and has held it in 7 quarters since.
Brevan Howard Capital Management's DexCom position peaked at $3.42M in Q4 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.